Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-03-14 | Raymond Debbane has been a director since August 2007. ... The current members of the corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2007 regarding the compensation of the non-employee members of our board of directors. ... Raymond Debbane $11,999 Fees Earned or Paid in Cash, $4,631 Option Awards, Total $16,630. |
| 2009-03-13 | The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. |
| 2009-06-05 | Raymond Debbane is designated by Invus as a member of the board of directors and has proportionate representation on the compensation committee and corporate governance committee. |
| 2010-03-19 | The following table presents summary information for the year ended December 31, 2009 regarding the compensation of the non-employee members of our board of directors. Samuel L. Barker, Ph.D. $48,500 $14,946 — $63,446 Philippe J. Amouyal $30,500 $7,473 — $37,973 Raymond Debbane $32,000 $7,473 — $39,473 Robert J. Lefkowitz, M.D. $28,500 $7,473 $50,000 (4) $85,973 Alan S. Nies, M.D. $30,000 $7,473 $75,000 (5) $112,473 Frank P. Palantoni $37,000 $7,473 — $44,473 Christopher J. Sobecki $27,000 $7,473 — $34,473 Judith L. Swain, M.D. $29,500 $7,473 — $36,973 Kathleen M. Wiltsey $28,000 $7,473 — $35,473 |
| 2012-03-16 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. Mr. Debbane is president and chief executive officer of The Invus Group, LLC, which he founded in New York in 1985 as the exclusive investment advisor of Benelux-based Artal Group S.A. |
| 2013-03-25 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. ... Mr. Debbane is a designee of Invus, L.P. and Invus C.V. pursuant to our stockholders’ agreement with Invus described under the heading “Transactions with Related Persons - Arrangements with Invus.” ... The following table presents summary information for the year ended December 31, 2012 regarding the compensation of the non-employee members of our board of directors. ... Raymond Debbane $44,563 Fees Earned or Paid in Cash, $25,922 Option Awards, $19,999 Restricted Stock Awards, Total $90,484. |
| 2014-03-14 | The following table presents summary information for the year ended December 31, 2013 regarding the compensation of the non-employee members of our board of directors. Name: Raymond Debbane Fees Earned or Paid in Cash: $45,500 Option Awards: $30,074 Restricted Stock Awards: $20,000 All Other Compensation: $0 Total: $95,574 |
| 2015-03-13 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. Chairman of the Board. Corporate Governance Committee chair. Director compensation table shows $91,965 total compensation in 2014. |
| 2016-03-18 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. ... The current members of our corporate governance committee are Raymond Debbane (chair), ... Director Compensation in 2015 ... Raymond Debbane $82,863 |
| 2017-03-17 | The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane, Dr. Lefkowitz and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... Director Compensation in 2016 ... Raymond Debbane ... $96,707 ... |
| 2018-03-16 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. Mr. Debbane provides us with the benefit of his extensive financial markets and investment expertise. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Mr. Debbane is “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. The following table presents summary information for the year ended December 31, 2017 regarding the compensation of the non-employee members of our board of directors. Raymond Debbane received total compensation of $96,424 in 2017. |
| 2019-03-15 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. ... Mr. Debbane is a designee of Invus, L.P. and Invus C.V. pursuant to our stockholders’ agreement with Invus described under the heading “Transactions with Related Persons - Arrangements with Invus.” ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2018 regarding the compensation of the non-employee members of our board of directors. ... Raymond Debbane $45,500 Fees Earned or Paid in Cash, $14,888 Option Awards, $19,999 Restricted Stock Awards, Total $80,387. |
| 2020-03-13 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. ... The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2019 regarding the compensation of the non-employee members of our board of directors. ... Raymond Debbane $74,067 Fees Earned or Paid in Cash, $24,460 Option Awards, $19,652 Restricted Stock Unit Awards, Total $118,179. |
| 2021-03-19 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. |
| 2022-04-08 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. Mr. Debbane is president and chief executive officer of The Invus Group, LLC, which he founded in New York in 1985 as the exclusive investment advisor of Benelux-based Artal Group S.A. Mr. Debbane serves as chairman of the board of directors of WW, Inc. and as chairman or director of a number of private companies in which Invus and Artal Group S.A. have invested. He previously served as a director of Blue Buffalo Pet Products, Inc. from 2007 until April 2018 when Blue Buffalo was acquired by General Mills, Inc. Before founding The Invus Group, Mr. Debbane was a manager in the Paris office of The Boston Consulting Group, Inc., where he did consulting work for a number of major European and international companies. Mr. Debbane holds an M.B.A. from Stanford University, an M.S. in food science and technology from the University of California at Davis, and a B.S in agricultural sciences and agricultural engineering from American University of Beirut. Mr. Debbane provides us with the benefit of his extensive financial markets and investment expertise gained in more than 30 years of leading the identification, selection, negotiation and oversight of a wide range of investments in his role as president and chief executive officer of The Invus Group, as well as his background in strategic consulting across a broad range of industries developed while with The Boston Consulting Group. Mr. Debbane is a designee of Invus, L.P. and its affiliates pursuant to our stockholders’ agreement with Invus described under the heading “Transactions with Related Persons - Arrangements with Invus.” Director Compensation in 2021: $130,621. |
| 2023-03-17 | The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. ... The following table presents summary information for the year ended December 31, 2022 regarding the compensation of the non-employee members of our board of directors. ... Raymond Debbane $85,000 Fees Earned or Paid in Cash, $20,387 Option Awards, $16,465 Restricted Stock Unit Awards, Total $121,852. |
| 2024-03-26 | Raymond Debbane has been a director since August 2007 and became chairman of our board of directors in February 2012. Mr. Debbane provides us with the benefit of his extensive financial markets and investment expertise. The current members of our corporate governance committee are Raymond Debbane (chair), Robert J. Lefkowitz, M.D. and Judith L. Swain, M.D. The following table presents summary information for the year ended December 31, 2023 regarding the compensation of the non-employee members of our board of directors. Raymond Debbane received $85,000 in fees and $42,824 in stock awards in 2023, totaling $127,824. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-21 | Raymond Debbane, Chairman of the Board of Directors The following table sets forth information concerning the compensation of our directors (other than directors who are named executive officers) for fiscal 2014. Raymond Debbane Fees Earned or Paid in Cash: $41,524 Stock Awards: $64,458 Total: $105,982 Member of the Compensation Committee. |
| 2016-04-06 | The current members of the Compensation Committee are Messrs. Debbane and Amouyal and Dr. Altschuler. The Chairman of the Compensation Committee is Mr. Debbane. The Compensation Committee held 8 meetings during fiscal 2015. ... Compensation Paid to Directors Serving on Committees of the Board of Directors Each director serving as a member of the Audit Committee is entitled to receive $10,000 per annum, payable quarterly, in cash. Each director who serves as Audit Committee chair receives an additional $10,000 per annum, payable quarterly, in cash. In addition, each director serving as a member of the Compensation Committee is entitled to receive $4,000 per annum, payable quarterly, in cash. ... Director Summary Compensation Table The following table sets forth information concerning the compensation of our directors (other than directors who are named executive officers) for fiscal 2015. Raymond Debbane $41,518 $60,342 $0 $0 $101,860 |
| 2017-04-03 | Mr. Debbane has been the Chairman of our Board of Directors since our acquisition by Artal Luxembourg on September 29, 1999. ... Mr. Debbane is a co-founder and the Chief Executive Officer of The Invus Group, LLC. ... Mr. Debbane is the Chairman of the Board of Directors of Lexicon Pharmaceuticals, Inc. and a director of Blue Buffalo Pet Products, Inc. He is also the Chief Executive Officer and a director of Artal Group S.A., and the Chairman of the Board of Directors of a number of private companies of which Artal or Invus, L.P. are shareholders. ... Member of the Compensation Committee. ... 2016 Director Compensation for fiscal 2016 ... Raymond Debbane ... Total 90,404. |
| 2018-04-05 | The current members of the Compensation Committee are Messrs. Debbane and Amouyal and Dr. Altschuler. The Chairman of the Compensation Committee is Mr. Debbane. ... Compensation Paid to Directors for fiscal 2017: Raymond Debbane $147,420. |
| 2019-04-05 | Raymond Debbane has been the Chairman of our Board of Directors since our acquisition by Artal Luxembourg on September 29, 1999. Mr. Debbane is a co-founder and the Chief Executive Officer of The Invus Group, LLC. ... The current members of the Compensation Committee are Messrs. Debbane and Sobecki and Dr. Altschuler. ... The Chairman of the Compensation Committee is Mr. Debbane. ... Director Compensation Table shows Raymond Debbane total compensation $156,548. |
| 2020-04-02 | Raymond Debbane has been the Chairman of our Board of Directors since our acquisition by Artal Luxembourg in September 1999. Mr. Debbane is a co-founder and the Chief Executive Officer of The Invus Group, LLC. ... The Board of Directors recommends that you vote FOR the election of each of the Class I director nominees. DIRECTOR COMPENSATION FOR FISCAL 2019 Raymond Debbane Fees Earned or Paid in Cash $81,050 Stock Awards $75,634 Total $156,684 Member of the Compensation Committee. |
| 2021-04-06 | The following table sets forth information concerning the compensation of our directors (other than Ms. Grossman who is a named executive officer) for fiscal 2020. DIRECTOR COMPENSATION FOR FISCAL 2020 Raymond Debbane $36,280 $72,815 — $109,095 |
| 2022-04-05 | The current members of the Compensation Committee are Dr. Altschuler, Messrs. Debbane and Sobecki and Ms. Dulski. Each member of the Compensation Committee has been determined to be independent under the applicable listing standards of Nasdaq and our Corporate Governance Guidelines. The Chairman of the Compensation Committee is Mr. Debbane. The Compensation Committee held 7 meetings during fiscal 2021. ... Director Summary Compensation Table ... Raymond Debbane $155,220 |
| 2023-04-03 | Raymond Debbane 68 Chairman of the Board of Directors Member of Compensation Committee. DIRECTOR COMPENSATION FOR FISCAL 2022 Raymond Debbane $81,013 Fees Earned or Paid in Cash $76,741 Stock Awards Total $157,754 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22